Merck
MRK
#51
Rank
S$368.65 B
Marketcap
S$147.59
Share price
2.39%
Change (1 day)
10.13%
Change (1 year)

EPS for Merck (MRK)

EPS in 2025 (TTM): S$9.97

According to Merck's latest financial reports the company's current EPS (TTM) is S$9.66. In 2024 the company made an earnings per share (EPS) of S$8.59 an increase over its 2023 EPS that were of S$0.19.

EPS history for Merck from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)S$9.9716.04%
2024S$8.594308.46%
2023S$0.19-97.32%
2022S$7.2910.92%
2021S$6.5784.68%
2020S$3.56-27.2%
2019S$4.8963.44%
2018S$2.99151.11%
2017S$1.19-54.58%
2016S$2.6230.21%
2015S$2.01-61.99%
2014S$5.29180.51%
2013S$1.89-31.82%
2012S$2.776.62%
2011S$2.60

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
S$13.27 37.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$9.36-3.08%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
S$2.19-77.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
S$10.24 6.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$26.09 170.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$16.57 71.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
S$4.71-51.20%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
S$3.78-60.89%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
S$4.57-52.65%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
S$0.80-91.70%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel